These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29392480)

  • 1. Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients.
    Gelhorn HL; Skalicky AM; Balantac Z; Eremenco S; Cimms T; Halling K; Hollen PJ; Gralla RJ; Mahoney MC; Sexton C
    Support Care Cancer; 2018 Jul; 26(7):2229-2238. PubMed ID: 29392480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma.
    Gelhorn HL; Eremenco S; Skalicky AM; Balantac Z; Cimms T; Halling K; Sexton C
    J Patient Rep Outcomes; 2017; 2(1):16. PubMed ID: 29749970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validation.
    Hollen PJ; Gralla RJ; Liepa AM; Symanowski JT; Rusthoven JJ
    Cancer; 2004 Aug; 101(3):587-95. PubMed ID: 15274072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso.
    Hollen PJ; Gralla RJ; Liepa AM; Symanowski JT; Rusthoven JJ
    Support Care Cancer; 2006 Jan; 14(1):11-21. PubMed ID: 15999264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pilot Mixed-Methods Study of Malignant Pleural Mesothelioma Symptoms.
    Walker SL; Vaughan Dickson V; Cacchione PZ
    Oncol Nurs Forum; 2022 Oct; 49(6):615-623. PubMed ID: 36413739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
    Williams LA; Whisenant MS; Mendoza TR; Haq S; Keating KN; Cuffel B; Cleeland CS
    Qual Life Res; 2018 Dec; 27(12):3229-3241. PubMed ID: 30187393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Qualitative Study to Assess the Content Validity of the 24-Hour Migraine Quality of Life Questionnaire in Patients with Migraine.
    Speck RM; Collins EM; Lombard L; Ayer DW
    Headache; 2020 Oct; 60(9):1982-1994. PubMed ID: 32748408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Symptom Management System for Patients with Malignant Pleural Mesothelioma (ASyMSmeso): Mixed Methods Study.
    Maguire R; Connaghan J; Arber A; Klepacz N; Blyth KG; McPhelim J; Murray P; Rupani H; Chauhan A; Williams P; McNaughton L; Woods K; Moylan A
    J Med Internet Res; 2020 Nov; 22(11):e19180. PubMed ID: 33180025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
    Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
    Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient motivators of postoperative electronic patient-reported outcome symptom monitoring use in thoracic surgery patients: a qualitative study.
    O'Leary MC; Kwong E; Cox C; Gentry AL; Stover AM; Vu MB; Carda-Auten J; Leeman J; Mody GN
    J Patient Rep Outcomes; 2024 Jul; 8(1):81. PubMed ID: 39060464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma.
    Cleeland CS; Keating KN; Cuffel B; Elbi C; Siegel JM; Gerlinger C; Symonds T; Sloan JA; Dueck AC; Bottomley A; Wang XS; Williams LA; Mendoza TR
    Sci Rep; 2024 Jun; 14(1):14839. PubMed ID: 38937473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural mesothelioma: treatment patterns and humanistic burden of disease in Europe.
    Moore A; Bennett B; Taylor-Stokes G; McDonald L; Daumont MJ
    BMC Cancer; 2022 Jun; 22(1):693. PubMed ID: 35739480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life?
    Hollen PJ; Gralla RJ; Kris MG; McCoy S; Donaldson GW; Moinpour CM
    Qual Life Res; 2005 Apr; 14(3):837-47. PubMed ID: 16022076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
    McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
    Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
    Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
    Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity.
    Askanase AD; Daly RP; Okado M; Neville K; Pong A; Hanrahan LM; Merrill JT
    Health Qual Life Outcomes; 2019 Jun; 17(1):99. PubMed ID: 31174541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom Burden and Unmet Needs in Malignant Pleural Mesothelioma: Exploratory Analyses From the RESPECT-Meso Study.
    Hoon SN; Lawrie I; Qi C; Rahman N; Maskell N; Forbes K; Gerry S; Monterosso L; Chauhan A; Brims FJH
    J Palliat Care; 2021 Apr; 36(2):113-120. PubMed ID: 32791881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial.
    McMullan C; Retzer A; Hughes SE; Aiyegbusi OL; Bathurst C; Boyd A; Coleman J; Davies EH; Denniston AK; Dunster H; Frost C; Harding R; Hunn A; Kyte D; Malpass R; McNamara G; Mitchell S; Mittal S; Newsome PN; Price G; Rowe A; van Reil W; Walker A; Wilson R; Calvert M
    J Patient Rep Outcomes; 2023 Oct; 7(1):98. PubMed ID: 37812323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study.
    Nagamatsu Y; Oze I; Aoe K; Hotta K; Kato K; Nakagawa J; Hara K; Kishimoto T; Fujimoto N
    BMC Cancer; 2018 Mar; 18(1):350. PubMed ID: 29587685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.